Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Subjects Affected by Acanthamoeba Keratitis
Condition: Acanthamoeba Keratitis Interventions: Drug: PHMB 0.08%; Drug: Propamidine 0.1%; Drug: placebo; Drug: PHMB 0.02% Sponsor: SIFI SpA Recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials